The Medicines Company (MDCO) Scheduled to Post Quarterly Earnings on Tuesday
The Medicines Company is set to issue its quarterly earnings data on Tuesday, September 16th. Parties interested in registering for the company's conference call can do so using this link .
The Medicines Company to Review ORBACTIVTM (oritavancin) Launch...
The Medicines Company has scheduled a conference call for Tuesday, September 16 at 7:30 a.m. Eastern Time to discuss plans for launching ORBACTIVTM for injection, the first and only single-dose, FDA-approved antibiotic for the treatment of adult patients with acute bacterial skin and skin structure infections caused by susceptible isolates of designated Gram-positive pathogens. Replay is available from 10:30 a.m. Eastern Time following the conference call through September 23, 2014.
Customer Interaction Solutions
The Medicines Company to Present New Data from its Infectious Disease ...
The Medicines Company today announced that a series of abstracts highlighting data from its Infectious Disease portfolio will be presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy , which takes place in Washington, DC from September 5-9, 2014.